Clinical Trials Study
Copyright ©The Author(s) 2024.
World J Cardiol. Mar 26, 2024; 16(3): 149-160
Published online Mar 26, 2024. doi: 10.4330/wjc.v16.i3.149
Table 1 Baseline characteristics and laboratory findings of the obesity in populations with and without heart failure with preserved ejection fraction, n (%)
Parameter
HFpEF+ (n = 17)
HFpEF- (n = 45)
P value
Age (yr)42.94 ± 3.3736.60 ± 1.800.0819
> 60A3 (17.6)1 (0.02)0.0275a
Male gender11 (64.7)25 (55.6)0.5227
BSA (m2)2.17 ± 0.072.13 ± 0.040.639
Weight (kg)102.60 ± 5.49103.00 ± 4.370.9667
BMI (kg/m2)35.78 ± 1.2833.5 ± 0.990.2093
Systolic blood pressure (mmHg)139.80 ± 4.73130.90 ± 1.840.0370a
Diastolic blood pressure (mmHg)86.59 ± 3.2182.51 ± 1.610.2174
Complications
Diabetes9 (20.0)4 (23.5)0.7653
Hypertension6 (35.3)6 (13.3)0.052
Hyperlipidemia8 (47.1)13 (28.9)0.1652
Hyperuricemia4 (23.5)12 (26.7)0.8051
Fatty liver10 (58.8)13 (28.9)0.0253a
Biomarkers
BNP (pg/mL)22.67 ± 5.2121.63 ± 2.950.86
Laboratory investigations
Serum cholesterol (mmol/L)5.01 ± 0.265.06 ± 0.160.8666
Serum triglycerides (mmol/L)2.13 ± 0.211.85 ± 0.170.3609
Serum HDL (mmol/L)1.06 ± 0.061.17 ± 0.030.0766
Serum LDL (mmol/L)3.05 ± 0.203.12 ± 0.130.7818
Table 2 Cardiac magnetic resonance parameters of chamber size, function, epicardial adipose tissue volume of the obesity in populations with and without heart failure with preserved ejection fraction
CMR parameters
HFpEF+ (n = 17)
HFpEF- (n = 45)
P value
Conventional parameters
LVEF (%)0.60 ± 0.030.64 ± 0.010.0797
LV mass index (g/m2)61.38 ± 4.5552.68 ± 1.400.0181a
LVEDD (mm)52.74 ± 1.8050.20 ± 0.570.0833
LVMWT (mm)10.32 ± 0.409.66 ± 0.250.1765
LVEDVi (mL/m2)74.00 ± 5.5269.16 ± 1.720.2716
LVESVi (mL/m2)32.12 ± 5.8724.84 ± 0.780.0592
LA AP diameter (mm)41.37 ± 1.5342.15 ± 0.870.6518
LA LR diameter (mm)67.85 ± 2.5570.63 ± 1.180.2686
Epicardial adipose tissue
EAT volume (mL)160.00 ± 7.13139.80 ± 5.390.0449a
EATi (mL/m2)74.20 ± 3.1665.37 ± 2.230.0360a
EAT mass (g)147.20 ± 6.56128.60 ± 4.980.0451a
EAT mass index (g/m2)68.26 ± 2.9160.10 ± 2.060.0359a
EAT/LA AP diameter ratio3.56 ± 0.183.11 ± 0.140.0843
EAT/LA LR diameter ratio2.19 ± 0.111.84 ± 0.080.0203a
EAT/LV mass ratio1.21 ± 0.091.17 ± 0.060.7737
EAT/LV volume ratio0.99 ± 0.080.92 ± 0.040.4158
Table 3 Relationships between epicardial adipose tissue and morphological and functional parameters in heart failure with preserved ejection fraction positive group
Pearson’s correlation (r, P)
EAT volume (mL)
EATi (mL/m2)
EAT mass (g)
EAT mass index (g/m2)
LVEF (%)-0.101, 0.6980.245, 0.343-0.101, 0.6980.245, 0.343
LV mass index (g/m2)0.286, 0.265-0.039, 0.8810.286, 0.265-0.039, 0.882
LVEDD (mm)0.083, 0.751-0.102, 0.6960.083, 0.751-0.102, 0.697
LVMWT (mm)0.022, 0.932-0.314, 0.2190.022, 0.932-0.314, 0.219
LVEDVi (mL/m2)-0.018, 0.946-0.213, 0.412-0.018, 0.946-0.213, 0.412
LVESVi (mL/m2)0.028, 0.916-0.213, 0.4110.028, 0.916-0.213, 0.411
LA AP diameter (mm)0.354, 0.1790.158, 0.5580.354, 0.1790.158, 0.558
LA LR diameter (mm)0.231, 0.3890.193, 0.4740.231, 0.3890.193, 0.474
Table 4 Variables associated with the heart failure with preserved ejection fraction in obesity population
VariablesLower/upper
Univariate analysis (OR, 95%CI, P value)Multivariate analysis (OR, 95%CI, P value)
Age (yr)1.040 (0.994, 1.088) 0.0871.046 (0.979, 1.117) 0.183
BMI (kg/m2)1.057 (0.969, 1.154) 0.213
BMI > 35 kg/m22.812 (0.558, 14.179) 0.210
Diabetes1.231 (0.323, 4.689) 0.761
Hypertension3.545 (0.952, 13.201) 0.0594.580 (1.008, 20.803) 0.049a
LVEF (%)0.002 (0.000, 7.482) 0.136
LVEDVi (mL/m2)1.020 (0.984, 1.058) 0.288
LVESVi (mL/m2)1.063 (0.958, 1.178) 0.249
LA AP diameter (mm)0.977 (0.884, 1.080) 0.646
LA LR diameter (mm)0.963 (0.900, 1.030) 0.267
EAT mass index (g/m2)1.049 (1.002, 1.098) 0.042a0.963 (1.054, 0.880) 0.416
EAT mass (g)1.020 (1.000, 1.041) 0.051
EATi (mL/m2)1.045 (1.002, 1.090) 0.042a
EAT volume (mL)1.019 (1.000, 1.038) 0.051
EAT/LA AP diameter ratio1.794 (0.915, 3.519) 0.089
EAT/LA LR diameter ratio3.989 (1.171, 13.584) 0.027a9.226 (1.070, 79.512) 0.043a
EAT/LV mass ratio1.236 (0.300, 5.098) 0.770
EAT/LV volume ratio2.299 (0.317, 16.658) 0.410
Table 5 Intra-observer and inter-observer reproducibility for epicardial adipose tissue parameters
Intra-observer
Inter-observer
CV (%)
ICC
95%CI
CV (%)
ICC
95%CI
EAT volume (mL)24.60.929(0.885, 0.939)18.40.900(0.746, 0.963)
EATi (mL/m2)23.00.913(0.846, 0.951)17.60.903(0.753, 0.964)
EAT mass (g)26.30.931(0.878, 0.962)17.90.900(0.746, 0.963)
EAT mass index (g/m2)23.70.913(0.846, 0.951)31.00.978(0.941, 0.992)
EAT/LA AP diameter ratio35.90.734(0.561, 0.846)18.50.882(0.696, 0.957)
EAT/LA LR diameter ratio28.40.710(0.526, 0.831)19.90.928(0.807, 0.974)
EAT/LV mass ratio34.70.870(0.774, 0.927)31.30.978(0.941, 0.992)
EAT/LV volume ratio29.40.929(0.874, 0.961)31.60.973(0.928, 0.963)